Search Results

Infliximab rather than tocilizumab for HLA-B52-positive Takayasu arteritis?

• Authors : Takamasu, Eisuke¹ (AUTHOR) ; Yokogawa, Naoto¹ (AUTHOR); Furukawa, Hiroshi² (AUTHOR)

Subjects: *ANTIRHEUMATIC agents; *BIOLOGICALS; *TAKAYASU arteritis

• Source: Clinical Rheumatology. Dec2024, Vol. 43 Issue 12, p4009-4011. 3p.

Record details

Correction: Paradoxical psoriasis induced by IL-17 inhibitors: a case series of patients with axial spondyloarthritis and a systematic literature review.

• Authors : Chaitidis, Nikolaos¹ (AUTHOR) ; Papadopoulou, Zoi² (AUTHOR); Varvara, Stavritsa Taxiarchoula^1,3 (AUTHOR)

Subjects: *TUMOR necrosis factors; *ANTIRHEUMATIC agents; *THERAPEUTICS

• Source: Rheumatology International. Nov2024, Vol. 44 Issue 11, p2669-2670. 2p.

Record details

Comparative study of paradoxical and classical psoriasis: what are clinical and therapeutic differences?

• Authors : Demir, Yusuf¹ (AUTHOR); Ak, Tumay² (AUTHOR) ; Temiz, Sera Nur Yucesoy¹ (AUTHOR)

Subjects: *PSORIASIS; *ANTIRHEUMATIC agents

• Source: Archives of Dermatological Research. Aug2024, Vol. 316 Issue 6, p1-4. 4p.

Record details

Abatacept and rituximab increase cancer risk in patients with RA.

Subjects: *ANTIRHEUMATIC agents; *DISEASE risk factors; *ABATACEPT

• Source: Reactions Weekly. Nov2024, Vol. 2036 Issue 1, p4-4. 1p.

Record details

Measles-specific antibodies loss after a single dose of MMR vaccine in children with oligo-articular JIA on methotrexate treatment: a single-center case-controlled study.

• Authors : Kopsidas, Ioannis¹ (AUTHOR) ; Mentesidou, Lida² (AUTHOR) ; Syggelou, Angeliki¹ (AUTHOR)

Subjects: *JUVENILE idiopathic arthritis; *ANTIRHEUMATIC agents; *MEDICAL sciences

• Source: Rheumatology International. Dec2024, Vol. 44 Issue 12, p3027-3033. 7p.

Record details

Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study.

• Authors : Schapink, Lisa¹ (AUTHOR) ; den Broeder, Nathan¹ (AUTHOR); den Broeder, Alfons A.^1,2 (AUTHOR)

Subjects: *ANTIRHEUMATIC agents; *RHEUMATOID arthritis; *BIOLOGICALS

• Source: Rheumatology International. Dec2024, Vol. 44 Issue 12, p2921-2925. 5p.

Record details

Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression.

• Authors : Soufivand, Parviz¹ (AUTHOR); Hosseini Torshizi, Ghazal² (AUTHOR); Roghani, Seyed Askar^1,3 (AUTHOR)

Subjects: *ANTIRHEUMATIC agents; *ENZYME-linked immunosorbent assay; *GENE expression

• Source: Inflammopharmacology. Dec2024, Vol. 32 Issue 6, p3687-3695. 9p.

Record details

>Efficacy of disease-modifying antirheumatic drugs in the treatment of granulomatous mastitis: a systematic review.

• Authors : Parperis, Konstantinos^1,2 (AUTHOR) ; Costi, Egli¹ (AUTHOR); Philippou, Sofia¹ (AUTHOR)

Subjects: *ANTIRHEUMATIC agents; *DRUG therapy; *OPEN access publishing

• Source: Rheumatology International. Nov2024, Vol. 44 Issue 11, p2371-2379. 9p.

Record details

Novel Management, Cure and Complications-Control of Rheumatoid Arthritis with Traditional and Modern Remedies (A Review).

• Authors : Dar, Eshwa¹ (AUTHOR); Abbas, Muhammad¹ (AUTHOR) ; Nazir, Sarwat² (AUTHOR)

Subjects: *ANTIRHEUMATIC agents; *ANTI-inflammatory agents; *JOINT stiffness

• Source: Pharmaceutical Chemistry Journal. Oct2024, Vol. 58 Issue 7, p1020-1028. 9p.

Record details

Etanercept/Methotrexate/Prednisone: Lack of efficacy and Tropheryma whipplei infection : case report.

Subjects: *ANTIRHEUMATIC agents; *PREDNISONE; *ETANERCEPT

• Source: Reactions Weekly. 7/27/2024, Vol. 2018 Issue 1, p199-199. 1p.

Record details